The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 28, 2022

Filed:

Sep. 21, 2012
Applicant:

Ecosynthetix Ltd., Lansing, MI (US);

Inventors:

Steven Bloembergen, Okemos, MI (US);

Ian J. McLennan, Burlington, CA;

Nathan Jones, Hamilton, CA;

Areet Krsna Ganesh Shermon, Waterloo, CA;

Abdel Elsayed, Waterloo, CA;

Juewen Liu, Kitchener, CA;

Assignee:

GREENMARK BIOMEDICAL INC., Lansing, MI (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/26 (2006.01); A61K 9/14 (2006.01); A61K 9/51 (2006.01); B82Y 5/00 (2011.01); A61K 9/16 (2006.01); C08B 31/18 (2006.01); C08B 33/00 (2006.01); C08B 35/00 (2006.01); A61K 47/54 (2017.01); A61K 47/69 (2017.01); C08B 31/00 (2006.01); A61K 31/704 (2006.01); A61K 47/36 (2006.01);
U.S. Cl.
CPC ...
A61K 9/145 (2013.01); A61K 9/1676 (2013.01); A61K 9/5161 (2013.01); A61K 31/704 (2013.01); A61K 47/549 (2017.08); A61K 47/6939 (2017.08); B82Y 5/00 (2013.01); C08B 31/003 (2013.01); C08B 31/185 (2013.01); C08B 33/00 (2013.01); C08B 35/00 (2013.01); A61K 47/36 (2013.01); Y10S 977/773 (2013.01); Y10S 977/906 (2013.01); Y10T 428/2982 (2015.01);
Abstract

A delivery device for a active agent comprises nanoparticles based on a biopolymer such as starch. The delivery device may also be in the form of an aptamer-biopolymer-active agent conjugate wherein the aptamer targets the device for the treatment of specific disorders, such as cancer. The delivery device survives for a period of time in the body sufficient to allow for transport and uptake of the delivery device into targeted cells. The degree of crosslinking can provide a desired release profile of the active agent at, near or inside the target cells. The nanoparticles may be made by applying a high shear force in the presence of a cross linker. The particles may be predominantly in the range of 50-150 nm and form a colloidal dispersion of crosslinked hydrogel particles in water.


Find Patent Forward Citations

Loading…